Lunit

328130.KQ

30.54 USD

-0.71

-2.27%

Overview

Last close

30.54 usd

Market cap

880.47M usd

52 week high

90.42 usd

52 week low

18.38 usd

Target price

74.4 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

45.5704

Price/Book Value

4.8891

Enterprise Value

852.12M usd

EV/Revenue

43.9953

EV/EBITDA

-45.3273

Key financials

Revenue TTM

19.37M usd

Gross Profit TTM

4.94M usd

EBITDA TTM

-42.87M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

453.95B usd

Net debt

N/A usd

About

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.